Is Wegovy Out of Stock Right Now — and What Are Your Options?

Why has Wegovy been out of stock so often?

When Novo Nordisk launched Wegovy for weight management in the UK, demand outpaced the global supply of semaglutide almost immediately. The same active ingredient sits inside Ozempic, which is licensed for type 2 diabetes, and as prescribing for both indications accelerated worldwide, manufacturing struggled to keep pace. This wasn't a British-only problem; countries across Europe and North America reported the same pattern.

The shortages that followed were uneven. Certain doses ran dry while others remained available; supply could be plentiful in one city and sparse in another simply because distribution logistics lagged behind demand. NHS England's guidance on weight management injections has been updated to reflect these supply realities, and the NICE appraisal for semaglutide (TA875) noted that commissioning would depend partly on sustained supply.

Things have improved. Novo Nordisk expanded manufacturing capacity through 2024 and 2025, and the approval of the new 7.2mg single-dose pen in April 2026 added a further format to the market. Shortages today tend to be localised and transient rather than blanket, though they have not disappeared entirely.

Which Wegovy doses have been hardest to find?

Stock problems have not affected every dose equally. Early in the shortage cycle, the lower doses (0.25mg and 0.5mg) were often more available because global demand concentrated on higher maintenance doses. That pattern has shifted, the picture now depends heavily on which pharmacy you approach and when.

If you have been trying to find a specific dose, it is worth checking a regulated online pharmacy directly rather than relying on secondhand reports from forums. Stock can turn over within days. A quick look at current Wegovy availability in the UK takes under a minute and gives you a more accurate answer than any forum thread from last month.

Patients who are mid-treatment and unable to source their usual dose face a particular difficulty: the clinical guidance is not to skip doses or improvise the schedule without speaking to the prescriber who manages their treatment. The NHS semaglutide medicines page is clear that patients should contact their healthcare team if they cannot obtain the medicine they have been prescribed, rather than substituting informally.

For those stuck on a specific dose, our page on 0.5mg Wegovy availability covers that dose in more detail, and 1mg stock information is covered separately.

Is buying from an unverified seller ever a reasonable workaround?

No, and the reasons are practical, not just regulatory. The MHRA has warned repeatedly that fake weight-loss pens are circulating in the UK, sold through social media and unregistered websites. In some cases, counterfeit pens have been found to contain insulin rather than semaglutide. Injecting an unknown substance in doses calibrated for a completely different medicine is a genuine medical emergency waiting to happen.

Around 20 million doses of illegally traded weight-loss medicines with an estimated street value of approximately £45 million were seized in 2025 enforcement operations. The scale of that problem reflects how many sellers are willing to exploit patients who are frustrated by legitimate shortages.

The safe check takes seconds: any online pharmacy legally dispensing Wegovy in the UK must be registered with the General Pharmaceutical Council. You can confirm this at the GPhC pharmacy register, if a seller is not listed there, walk away. A seller offering the medicine without asking for a consultation or a prescription is a clear warning sign, not a convenience.

What practical options do people in the UK actually have?

If Wegovy is temporarily out of stock where you usually source it, there are a few sensible steps. First, contact your prescriber or pharmacy, many will hold your place in a supply queue or can advise on timing. Second, consider whether your current dose or format could be sourced differently; our guide to buying Wegovy online from a UK-registered pharmacy explains the regulated routes available.

Third, it is worth knowing that tirzepatide (Mounjaro) is a separately licensed weight management medicine that some patients and prescribers consider when semaglutide is unavailable. The two medicines work differently and the clinical suitability question is one for a prescriber, not a forum. You can read more about the cost context for Wegovy if you are weighing up options.

If you have not yet started treatment and are trying to work out the most practical route, a free consultation with a GPhC-registered prescriber is the place to begin. A real clinician reviews every consultation at nume, same day, not software. Check your eligibility by visiting our weight loss treatments page.